Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Emami

Showing results (81-90 of 142) with videos related to

Pageof 15
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 15, 1993
A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07R W Byhardt, T F Pajak, B Emami, et al.
AJR. American Journal of Roentgenology|October 1, 1984
Differentiation of radiation fibrosis from recurrent pulmonary neoplasm by magnetic resonance imagingH S Glazer, R G Levitt, J K Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 1993
The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)--analysis of a Radiation Therapy Oncology Group (RTOG) protocolR W Byhardt, L Martin, T F Pajak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1990
A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11J D Cox, N Azarnia, R W Byhardt, et al.
American Journal of Clinical Oncology|October 1, 1989
Deep regional hyperthermia of the liver. A clinical study of 49 patientsZ Petrovich, B Langholz, D S Kapp, et al.
Gynecologic Oncology|February 22, 2005
Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancerK V Albuquerque, R Singla, R K Potkul, et al.
American Journal of Clinical Oncology|December 1, 1991
Regional hyperthermia in patients with recurrent genitourinary cancerZ Petrovich, B Emami, D Kapp, et al.
International Journal of Radiation Oncology, Biology, Physics|July 30, 1994
Three-dimensional radiation treatment planning study for patients with carcinoma of the lungM V Graham, J W Matthews, W B Harms, et al.
The Laryngoscope|April 1, 1995
Squamous cell carcinoma of the pyriform sinus: a nonrandomized comparison of therapeutic modalities and long-term resultsJ G Spector, D G Sessions, B Emami, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1988
Hyperthermia in combination with definitive radiation therapy: results of a Phase I/II RTOG StudyR Scott, B Gillespie, C A Perez, et al.
Pageof 15

Showing results (81-90 of 142) with videos related to

Sort By:
Pageof 15
International Journal of Radiation Oncology, Biology, Physics|June 15, 1993
A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07R W Byhardt, T F Pajak, B Emami, et al.
AJR. American Journal of Roentgenology|October 1, 1984
Differentiation of radiation fibrosis from recurrent pulmonary neoplasm by magnetic resonance imagingH S Glazer, R G Levitt, J K Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 1993
The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)--analysis of a Radiation Therapy Oncology Group (RTOG) protocolR W Byhardt, L Martin, T F Pajak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1990
A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11J D Cox, N Azarnia, R W Byhardt, et al.
American Journal of Clinical Oncology|October 1, 1989
Deep regional hyperthermia of the liver. A clinical study of 49 patientsZ Petrovich, B Langholz, D S Kapp, et al.
Gynecologic Oncology|February 22, 2005
Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancerK V Albuquerque, R Singla, R K Potkul, et al.
American Journal of Clinical Oncology|December 1, 1991
Regional hyperthermia in patients with recurrent genitourinary cancerZ Petrovich, B Emami, D Kapp, et al.
International Journal of Radiation Oncology, Biology, Physics|July 30, 1994
Three-dimensional radiation treatment planning study for patients with carcinoma of the lungM V Graham, J W Matthews, W B Harms, et al.
The Laryngoscope|April 1, 1995
Squamous cell carcinoma of the pyriform sinus: a nonrandomized comparison of therapeutic modalities and long-term resultsJ G Spector, D G Sessions, B Emami, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1988
Hyperthermia in combination with definitive radiation therapy: results of a Phase I/II RTOG StudyR Scott, B Gillespie, C A Perez, et al.
Pageof 15